Myocardial imaging with 123I-hexadecenoic acid

Area of Science:

• Cardiology
• Nuclear Medicine
• Biomedical Imaging

Background:

• Myocardial perfusion imaging is crucial for diagnosing heart conditions.
• Current methods may require stress tests or have limitations in distinguishing tissue viability.

Purpose of the Study:

• To evaluate 123I-hexadecenoic acid as a single-agent for myocardial perfusion and viability assessment.
• To determine the utility of this fatty acid analog in imaging ischemic and infarcted tissues.

Main Methods:

• Utilizing a terminally iodinated, 17-carbon fatty acid analog (123I-hexadecenoic acid).
• Assessing regional myocardial distribution patterns and clearance rates.
• Acquiring qualitative multiprojection and quantifiable single projection images.

Main Results:

• 123I-hexadecenoic acid is rapidly degraded in the myocardium.
• The agent allows for estimation of regional myocardial perfusion.
• Viable ischemic tissue can be distinguished from infarcted tissue.
• High count rates enable rapid image acquisition (3 min/view qualitative, 10 min/view quantitative).

Conclusions:

• 123I-hexadecenoic acid demonstrates potential as a valuable tool in nuclear cardiology.
• It may aid in diagnosing ischemic defects in patients with angina without stress.
• Further research can establish its role in routine clinical practice.